CJJD NASDAQ
China Jo-Jo Drugstores, Inc.
1W: +12.6%
1M: -34.8%
3M: -44.7%
1Y: -67.4%
3Y: -98.7%
5Y: -99.7%
$1.52
Last traded 2025-03-31 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Revenue Segmentation
By Product / Service
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$155M
+3.8% ▲
5Y CAGR: +7.5%
Gross Profit
$31M
-9.3% ▼
5Y CAGR: +4.4%
Operating Income
-$4M
+66.5% ▲
Net Income
-$4M
+80.0% ▲
EPS (Diluted)
$-2.93
+92.9% ▲
EBITDA
$1M
+106.1% ▲
5Y CAGR: +35.7%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $117M | $133M | $164M | $149M | $155M |
| YoY Growth | +9.1% | +13.5% | +23.5% | -9.5% | +3.8% |
| Cost of Revenue | $92M | $104M | $128M | $115M | $123M |
| Gross Profit | $26M | $29M | $37M | $34M | $31M |
| Gross Margin | 21.8% | 22.0% | 22.2% | 23.0% | 20.1% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $32M | $38M | $39M | $45M | $35M |
| Operating Expenses | $32M | $38M | $39M | $45M | $35M |
| Operating Income | -$6M | -$9M | -$3M | -$11M | -$4M |
| Operating Margin | -5.4% | -6.5% | -1.5% | -7.1% | -2.3% |
| Interest Expense | $699K | $455K | $262K | $66K | $14K |
| Income Before Tax | -$6M | -$8M | -$2M | -$21M | -$4M |
| Tax Expense | $16K | $32K | $1M | $395K | $63K |
| Net Income | -$6M | -$8M | -$3M | -$21M | -$4M |
| Net Margin | -5.5% | -6.3% | -1.9% | -14.2% | -2.7% |
| EPS (Diluted) | $-2.30 | $-49.29 | $-15.97 | $-41.46 | $-2.93 |
| EBITDA | -$4M | -$6M | -$580K | -$20M | $1M |
| Shares Outstanding | 3M | 169919 | 200334 | 509827 | 1M |